MAP3K14
Mitogen-activated protein kinase kinase kinase 14
Also known as: FTDCR1B, HS, HSNIK, M3K14_HUMAN, NIK
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99558
- Gene
- MAP3K14
- Ensembl
- ENSG00000006062
- Chromosome
- 17
- Canonical length
- 947 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes mitogen-activated protein kinase kinase kinase 14, which is a serine/threonine protein-kinase. This kinase binds to TRAF2 and stimulates NF-kappaB activity. It shares sequence similarity with several other MAPKK kinases. It participates in an NF-kappaB-inducing signalling cascade common to receptors of the tumour-necrosis/nerve-growth factor (TNF/NGF) family and to the interleukin-1 type-I receptor. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
947 residues, UniProt reviewed canonical sequence.
>Q99558|MAP3K14
1 MAVMEMACPG APGSAVGQQK ELPKAKEKTP PLGKKQSSVY KLEAVEKSPV FCGKWEILND
61 VITKGTAKEG SEAGPAAISI IAQAECENSQ EFSPTFSERI FIAGSKQYSQ SESLDQIPNN
121 VAHATEGKMA RVCWKGKRRS KARKKRKKKS SKSLAHAGVA LAKPLPRTPE QESCTIPVQE
181 DESPLGAPYV RNTPQFTKPL KEPGLGQLCF KQLGEGLRPA LPRSELHKLI SPLQCLNHVW
241 KLHHPQDGGP LPLPTHPFPY SRLPHPFPFH PLQPWKPHPL ESFLGKLACV DSQKPLPDPH
301 LSKLACVDSP KPLPGPHLEP SCLSRGAHEK FSVEEYLVHA LQGSVSSGQA HSLTSLAKTW
361 AARGSRSREP SPKTEDNEGV LLTEKLKPVD YEYREEVHWA THQLRLGRGS FGEVHRMEDK
421 QTGFQCAVKK VRLEVFRAEE LMACAGLTSP RIVPLYGAVR EGPWVNIFME LLEGGSLGQL
481 VKEQGCLPED RALYYLGQAL EGLEYLHSRR ILHGDVKADN VLLSSDGSHA ALCDFGHAVC
541 LQPDGLGKSL LTGDYIPGTE THMAPEVVLG RSCDAKVDVW SSCCMMLHML NGCHPWTQFF
601 RGPLCLKIAS EPPPVREIPP SCAPLTAQAI QEGLRKEPIH RVSAAELGGK VNRALQQVGG
661 LKSPWRGEYK EPRHPPPNQA NYHQTLHAQP RELSPRAPGP RPAEETTGRA PKLQPPLPPE
721 PPEPNKSPPL TLSKEESGMW EPLPLSSLEP APARNPSSPE RKATVPEQEL QQLEIELFLN
781 SLSQPFSLEE QEQILSCLSI DSLSLSDDSE KNPSKASQSS RDTLSSGVHS WSSQAEARSS
841 SWNMVLARGR PTDTPSYFNG VKVQIQSLNG EHLHIREFHR VKVGDIATGI SSQIPAAAFS
901 LVTKDGQPVR YDMEVPDSGI DLQCTLAPDG SFAWSWRVKH GQLENRPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAP3K14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 25 nTPM
- lymph node: 17 nTPM
- tonsil: 15 nTPM
- colon: 14 nTPM
- thymus: 13 nTPM
- appendix: 12 nTPM
Single-cell type
- epicardial cells: 130 nCPM
- cdc: 127 nCPM
- renal connecting tubule cells: 123 nCPM
- myosatellite cells: 113 nCPM
- epididymal basal cells: 110 nCPM
- microglia: 108 nCPM
Immune cell
- naive B-cell: 4.4 nTPM
- memory B-cell: 4.2 nTPM
- T-reg: 3 nTPM
- classical monocyte: 2 nTPM
- NK-cell: 2 nTPM
- intermediate monocyte: 1.8 nTPM
Brain region
- basal ganglia: 13 nTPM
- thalamus: 13 nTPM
- midbrain: 13 nTPM
- medulla oblongata: 11 nTPM
- hippocampal formation: 9.8 nTPM
- pons: 9.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAP3K14.
Disease | AllUniProt
Conditions MAP3K14 is implicated in, by any mechanism.
- Immunodeficiency 112 (IMD112) MIM:620449
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 557 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- NIK deficiency
- Immunodeficiency 112
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to mechanical stimulus
- defense response to virus
- immune response
- MAPK cascade
- non-canonical NF-kappaB signal transduction
Molecular functions
- ATP binding
- MAP kinase kinase kinase activity
- protein kinase activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- Mitogen-activated protein kinase kinase kinase
- Protein kinase domain
- Mitogen-activated protein (MAP) kinase kinase kinase 14
- M3K14, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAP3K14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAP3K14 as an antibody target. Whether an autoantibody or antibody against MAP3K14 could matter depends on whether native MAP3K14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAP3K14 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAP3K14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...